DXCM
$524.48
Dexcom
$9.95
1.93%
DXCM
Earnings Whisper ®
N/A
3rd Quarter September 2021
Consensus:  $0.62
Revenue:  N/A
Thursday
Oct 28
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Guidance announcement made Thursday, July 29, 2021
Latest EPS
Thursday, July 29, 2021

What do you expect when DXCM reports earnings?
Beat
Meet
Miss

Where is DXCM's stock price going from here?
Up
Flat
Down
Stock chart of DXCM
Analysts
Summary of analysts' recommendations for DXCM
Score
Grade
Pivots
Resistance
$537.32
$532.21
$523.37

$518.26

Support
$509.42
$504.31
$495.47
Tweet
Growth
Description
Dexcom Inc. is developing continuous glucose monitoring systems for people with diabetes.
Peers
StrykerBoston ScientificAbbottBaxter InternationalBecton, DickinsonResMedWaters3MTeleflexCardiovascular Systems